CASQ2
Calsequestrin-2 | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | ? | ||||||
HGNC | 1514 | ||||||
OMIM | 114251 | ||||||
RefSeq | NM_001232 | ||||||
UniProt | P31230 | ||||||
|
Calsequestrin-2 (CASQ2) is a protein encoded by the CASQ2 gene in humans. It is a high-capacity, moderate-affinity calcium-binding protein that plays a crucial role in the regulation of calcium ion concentration within the sarcoplasmic reticulum of cardiac muscle cells.
Function[edit | edit source]
Calsequestrin-2 is primarily found in the sarcoplasmic reticulum of cardiac muscle cells, where it serves as a major calcium storage protein. It binds calcium ions with moderate affinity but high capacity, allowing the sarcoplasmic reticulum to sequester large amounts of calcium. This storage is essential for the proper functioning of cardiac muscle contraction and relaxation cycles.
During muscle contraction, calcium ions are released from the sarcoplasmic reticulum into the cytoplasm, triggering the interaction between actin and myosin filaments, which leads to muscle contraction. Calsequestrin-2 helps regulate this process by buffering calcium ions and ensuring their rapid release and uptake.
Clinical Significance[edit | edit source]
Mutations in the CASQ2 gene have been associated with Catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare genetic disorder characterized by abnormal heart rhythms in response to physical activity or stress. CPVT can lead to syncope, seizures, or sudden cardiac death if not properly managed.
CASQ2 mutations disrupt the normal calcium buffering capacity of calsequestrin-2, leading to abnormal calcium handling in cardiac cells. This can result in arrhythmias due to inappropriate calcium release during the cardiac cycle.
Research[edit | edit source]
Research into CASQ2 and its role in cardiac physiology and pathology is ongoing. Studies focus on understanding the molecular mechanisms by which CASQ2 mutations lead to CPVT and exploring potential therapeutic interventions to correct or mitigate these effects.
Also see[edit | edit source]
- Sarcoplasmic reticulum
- Calcium signaling
- Cardiac muscle
- Catecholaminergic polymorphic ventricular tachycardia
- Calcium-binding proteins
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD